Gem Aromatics Limited
IPO Timeline
About Gem Aromatics Limited
The company is an established manufacturer of specialty ingredients, including, essential oils, aroma chemicals and Value Added Derivatives in India with a track record of over two decades. The Company offers a diversified portfolio of products, ranging from the Mother Ingredients to its various Value-Added Derivatives. The Company’s products find application across a broad spectrum of industries, such as, oral care, cosmetics, nutraceuticals, pharmaceuticals, wellness and pain management and personal care. The Company is one of the prominent essential oils and Value-Added Derivatives manufacturers in India, based on value and volume manufactured, specializing in products that are derived from mint and clove oil. The Company has a dominant presence in essential oil-based products and derivatives that are manufactured from mint, clove, eucalyptus oils and other essential oils. During FY 2024 in India, they were the largest procurer of Piperita oil, and the largest processor of DMO, Clove oil, Eugenol and Eucalyptus Oil in terms of volume manufactured.
Gem Aromatics Limited Subscription Status
| Date | QIB | NII | Retail | Total |
|---|---|---|---|---|
| TBA | 0 | 0 | 0 | 0 |
| TBA | 0 | 0 | 0 | 0 |
Gem Aromatics Limited financials Status
| Particulars (in Rs. Crores) | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 534.52 | 368.57 | 295.76 |
| Total Income | 505.64 | 454.23 | 425.09 |
| Profit After Tax | 53.38 | 50.10 | 44.67 |
| EBITDA | 88.45 | 78.35 | 66.19 |
| Net Worth | 283.98 | 230.55 | 179.53 |
| Reserves and Surplus | 278.26 | 224.88 | 182.36 |
| Total Borrowing | 222.37 | 111.13 | 89.36 |
Gem Aromatics Limited SWOT Analysis
Strengths
- Wide product range with continuous product development and R&D capabilities.
- Long-standing relationship with well-established customers in India and globally.
- Strategically located manufacturing facilities with a focus on sustainability.
- Experienced promoters and management team.
Risks
- The company is involved in an ongoing Supreme Court litigation concerning the land of their Budaun Facility. An adverse outcome could negatively impact their business, operations, finances, and cash flow.
- Rising raw material costs may reduce the company’s revenue and profitability, adversely affecting its business, operations, and financial condition.
- A significant portion of the company’s revenue comes from a limited number of geographies.
- In Fiscal 2024, the top 10 suppliers accounted for 68.61% of expenses. Losing or facing supply issues with them could harm the company’s revenue and profitability.
Frequently Asked Questions
What is the price band of the IPO?
The Price Band of the IPO is ₹309 to ₹325 per share
What is the size of the company?
The total issue size of the company is ₹451.25 Cr
